Bryan Klassen is a Neurology physician affiliated with WinnMed. OpenAlex indexes 131 publications with 2,647 citations (h-index 27); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 1st St SW
Rochester, MN 559050001
Telephone
507-284-2511Provider last certified this registry record 14 Aug 2020.
Clinical trials
- A Study of Wearable Device in Essential Tremor Patients
Sponsor: Mayo Clinic
- High Frequency Oscillations in Neurologic Disease
Sponsor: Mayo Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20241 payment
- Medtronic, Inc.Program year20232 payments
- Abbott LaboratoriesProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
98.5%Neuromuscular Blocker98.4%Incobotulinumtoxin a75%Onabotulinumtoxina26%Part B, office-administered≥48 patientsgamma-Aminobutyric Acid-ergic Agonist0.1%Baclofen100%Part D<11 patientsNervous system
1.4%Aromatic Amino Acid Decarboxylation Inhibitor1.1%Carbidopa-Levodopa67%Carbidopa-Levodopa Er25%Rytary7%Part D<11 patientsInfluenza A M2 Protein Inhibitor0.2%Amantadine100%Part D<11 patients+ 1 more class in this area
Anti-infectives
0.1%Penicillins with extended spectrum0.1%Amoxicillin100%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria
Annals of Clinical and Translational Neurology
2023 - Deep Brain Stimulator Device Infection: The Mayo Clinic Rochester Experience
Open Forum Infectious Diseases
2022 - Effectiveness of Thalamic Ventralis Oralis Anterior and Posterior Nuclei Deep Brain Stimulation for Posttraumatic Dystonia
Mayo Clinic Proceedings Innovations Quality & Outcomes
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Mayank Sardana, MD
WinnMed
Rakesh Suri, MD
WinnMed
Jorge Rakela, MD
WinnMed
Hugo Vargas, MD
WinnMed
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”